Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
PMID 38385640
It was reclassified from FDA Category 2 (restricted) back to Category 1 (compoundable) following HHS Secretary RFK Jr.s announcement on February 27, 2026
Angie Schaefer joins us on The Morning Blend to share the components of weight loss
Results BPC-157 accelerates wound closure in alkali-burned rats During the study, no abnormalities were observed in the general condition and behavior of rats in all treatment cohorts, including asitia, nausea, diarrhea, cough, or weight loss, and no symptoms of allergic response such as hydroposia or localized rash occurred in animals receiving bFGF or BPC-157
US$ 23.99
US$ 23.04
US$ 28.76
